Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Malformin C preferentially kills glioblastoma stem-like cells via concerted induction of proteotoxic stress and autophagic flux blockade.
Phillips E, van Enk S, Kildgaard S, Schlue S, Göttmann M, Jennings V, Bethke F, Müller G, Herold-Mende C, Pastor-Flores D, Schneider M, Helm D, Ostenfeld Larsen T, Goidts V. Phillips E, et al. Among authors: herold mende c. Mol Oncol. 2024 Oct 27. doi: 10.1002/1878-0261.13756. Online ahead of print. Mol Oncol. 2024. PMID: 39462997 Free article.
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, Preusser M, Herold-Mende C, Tatagiba M, Tabatabai G, Sahm F, von Deimling A; International Consortium on Meningiomas; Zadeh G, Aldape KD. Nassiri F, et al. Neuro Oncol. 2019 Jul 11;21(7):901-910. doi: 10.1093/neuonc/noz061. Neuro Oncol. 2019. PMID: 31158293 Free PMC article.
Distinct epigenetic and transcriptional profiles of Epstein-Barr virus (EBV) positive and negative primary CNS lymphomas.
Hai L, Friedel D, Hinz F, Hoffmann DC, Doubrovinskaia S, Rohdjess H, Weidenauer K, Denisova E, Scheffler GT, Kessler T, Kourtesakis A, Herold-Mende C, Henegariu O, Baehring JM, Dietrich J, Brors B, Wick W, Sahm F, Kaulen LD. Hai L, et al. Among authors: herold mende c. Neuro Oncol. 2024 Nov 22:noae251. doi: 10.1093/neuonc/noae251. Online ahead of print. Neuro Oncol. 2024. PMID: 39575767
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma.
Ippen FM, Hielscher T, Friedel D, Göbel K, Reuss D, Herold-Mende C, Krieg S, Deimling AV, Wick W, Sahm F, Suwala AK. Ippen FM, et al. Among authors: herold mende c. Neuro Oncol. 2024 Nov 12:noae238. doi: 10.1093/neuonc/noae238. Online ahead of print. Neuro Oncol. 2024. PMID: 39530475
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma.
Alhalabi OT, Göttmann M, Gold MP, Schlue S, Hielscher T, Iskar M, Kessler T, Hai L, Lokumcu T, Cousins CC, Herold-Mende C, Heßling B, Horschitz S, Jabali A, Koch P, Baumgartner U, Day BW, Wick W, Sahm F, Krieg SM, Fraenkel E, Phillips E, Goidts V. Alhalabi OT, et al. Among authors: herold mende c. Cancer Lett. 2024 Nov 28;605:217265. doi: 10.1016/j.canlet.2024.217265. Epub 2024 Sep 25. Cancer Lett. 2024. PMID: 39332586 Free article.
The Molecular and Immunological Landscape of Meningiomas.
Lotsch C, Warta R, Herold-Mende C. Lotsch C, et al. Among authors: herold mende c. Int J Mol Sci. 2024 Sep 5;25(17):9631. doi: 10.3390/ijms25179631. Int J Mol Sci. 2024. PMID: 39273576 Free PMC article. Review.
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma.
Wang JZ, Patil V, Landry AP, Gui C, Ajisebutu A, Liu J, Saarela O, Pugh SL, Won M, Patel Z, Yakubov R, Kaloti R, Wilson C, Cohen-Gadol A, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F, Almiron Bonnin DA, Holland EC, Kruser TJ, Barnholtz-Sloan JS, Sloan AE, Horbinski C, Chotai S, Chambless LB, Gao A, Rebchuk AD, Makarenko S, Yip S, Sahm F, Maas SLN, Tsang DS; International Consortium on Meningiomas (ICOM); Rogers CL, Aldape K, Nassiri F, Zadeh G. Wang JZ, et al. Nat Med. 2024 Nov;30(11):3173-3183. doi: 10.1038/s41591-024-03167-4. Epub 2024 Aug 21. Nat Med. 2024. PMID: 39169220 Free PMC article.
Hypoxia-driven heterogeneous expression of α5 integrin in glioblastoma stem cells is linked to HIF-2α.
Messé M, Bernhard C, Foppolo S, Thomas L, Marchand P, Herold-Mende C, Idbaih A, Kessler H, Etienne-Selloum N, Ochoa C, Tambar UK, Elati M, Laquerriere P, Entz-Werle N, Martin S, Reita D, Dontenwill M. Messé M, et al. Among authors: herold mende c. Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167471. doi: 10.1016/j.bbadis.2024.167471. Epub 2024 Aug 21. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 39154793 Free article.
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma.
Maas SLN, Hielscher T, Sievers P, Hovestadt V, Suwala AK, Acker T, Weller M, Preusser M, Herold-Mende C, Wick W, von Deimling A, Berghaus N, Sahm F. Maas SLN, et al. Among authors: herold mende c. Acta Neuropathol. 2024 Aug 8;148(1):17. doi: 10.1007/s00401-024-02777-z. Acta Neuropathol. 2024. PMID: 39115604 Free PMC article. No abstract available.
413 results